UNSPSC 51191515: Hydrochlorothiazide

This classification denotes a thiazide diuretic with the molecular formula C7H8ClN3O4S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0J48LPH2TH, chemically known as 6-chloro-7-sulfamoyl-2h-1,2,4-benzothiadiazine 1,1-dioxide but generally known as hydrochlorothiazide, which bears US NIH Compound Identifier 2720. European Medicines Agency schedules Hydrochlorothiazide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08062MIG.

UNSPSC 51191515 Hydrochlorothiazide is a Commodity code that, based on recent state and local solicitations, does not align with the procurement activity being tagged under it. The three most recent opportunities posted under this code are for wastewater treatment valves and repair services (Broward County, Florida), parenteral nutrition and intravenous solutions for correctional healthcare (Washington State Department of Corrections), and sodium bisulfite chemical supply for municipal water treatment (City of Meriden, Connecticut). None of these items are hydrochlorothiazide or pharmaceutical products. The mismatch suggests either a data classification error in the state and local procurement systems or that this code is being misapplied to unrelated commodity classes. The issuing bodies span state departments, counties, and cities, and the scopes range from specialized medical supply delivery with strict time windows and temperature control to industrial chemical supply for water pollution control facilities. This code shows minimal recent activity that is genuinely relevant to its stated pharmaceutical focus.

Geographic spread across recent activity includes Florida, Washington State, and Connecticut, with no concentration pattern evident. The Washington State Department of Corrections RFQ for parenteral products, services and equipment (due October 7, 2026) represents the largest scope, soliciting qualified suppliers across eight correctional facilities with multi-year contract terms through June 30, 2030 and set-aside opportunities for small, minority-owned, women-owned, and veteran-owned businesses. The Broward County RFI for DeZurik/APCO valves and repair services (due September 29, 2026) is narrowly focused on wastewater treatment equipment, and the City of Meriden IFB for sodium bisulfite (due July 29, 2026, already closed) targets municipal water treatment. Business development professionals should verify whether opportunities posted under this code in their target jurisdictions represent actual pharmaceutical or drug procurement, given the present misalignment between the code's nominal scope and recent solicitation activity.